Ifp Advisors, Inc Compugen LTD Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$1.57 - $3.33 $78 - $166	50 New	50 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.57 - $3.33 $78 - $166	-50 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$5.8 - $8.02 $290 - $401	50 New	50 $1,000
Q2 2021 Jul 13, 2021	BUY	$6.87 - $9.16 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$7.67 - $13.77 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$12.07 - $17.95 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$14.16 - $19.45 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$6.97 - $17.12 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$5.79 - $11.83 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$3.9 - $6.16 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$3.01 - $4.49 $0 - $0	0 New	0 $0

13.1M

79.2K

12.7K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $131M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.